The official twitter account for the Informa Connect Drug Delivery portfolio. Your home for all things drug delivery partnerships.
Joined July 2009
- Tweets4.3K
- Following1.2K
- Followers1.2K
- Likes82
Pinned Tweet
We are monitoring the ongoing developments with COVID-19 closely and following government and health organization guidelines. Our website provides the most up to date information on all our events informaconnect.com/biotech-p…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Naked systems with lipophilic conjugates are now the most common form of local delivery for macromolecular drugs, according to our latest report. #drugdelivery #peptides spr.ly/6017yyXiP
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Our latest report looks at Diversity, Equity and Inclusion in the Life Sciences. Based on an exclusive study of 483 pharma professionals, it provides in depth data on what challenges the industry still faces and how companies are tackling them informa.turtl.co/story/diver…
Naked systems with lipophilic conjugates are now the most common form of local delivery for macromolecular drugs, according to our latest report. #drugdelivery #peptides spr.ly/6015y1YEN